Overview

A Study of TRK-170 for the Treatment of Crohn's Disease

Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
In Crohn's Disease Patients - To evaluate the efficacy of TRK-170 - To evaluate the PK characteristics of TRK-170 - To assess the safety of TRK-170
Phase:
Phase 2
Details
Lead Sponsor:
Toray Industries, Inc